Liquid pharmaceutical composition containing teriparatide having excellent pharmacokinetics and / or safety

摘要

In a liquid pharmaceutical preparation for human subcutaneous administration containing 28.2 μg of teriparatide or a salt thereof (component 1) as a single dose in terms of teriparatide, the concentration of component 1 is 80 to 240 μg / mL. This liquid pharmaceutical preparation is excellent from the viewpoint of pharmacokinetics.